Real-world experience with sepiapterin in phenylketonuria: A single-center retrospective analysis
{{output}}
Background: Phenylketonuria (PKU) is an inborn error of metabolism caused by phenylalanine hydroxylase (PAH) deficiency. Sepiapterin, the most recently FDA-approved therapeutic for PKU, is indicated for sepiapterin-responsive PKU... ...
